Volume 7, Number 3, September 2017
|Number of page(s)||13|
|Published online||25 August 2017|
Transglutaminase 2 in human diseases
Dental Biochemistry, Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen
2 Department of Pediatrics and Biochemistry and Molecular Biology, University of Debrecen, Debrecen 4010, Hungary
3 Celiac Disease Center, Heim Pál Children’s Hospital, Budapest 1089, Hungary
4 Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen 4010, Hungary
5 Division of Immunology and Rheumatology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan
6 School of medicine, College of Medicine, China Medical University, Taichung 404, Taiwan
* Corresponding author. Department of Dental Biochemistry Signaling and Apoptosis Research Group Research Center of Molecular Medicine University of Debrecen H-4012 Debrecen Nagyerdei krt. 98. Hungary. E-mail address: email@example.com (Zsuzsa Szondy).
Accepted: 15 May 2017
Transglutaminase 2 (TG2) is an inducible transamidating acyltransferase that catalyzes Ca(2+)-dependent protein modifications. In addition to being an enzyme, TG2 also serves as a G protein for several seven transmembrane receptors and acts as a co-receptor for integrin β1 and β3 integrins distinguishing it from other members of the transglutaminase family. TG2 is ubiquitously expressed in almost all cell types and all cell compartments, and is also present on the cell surface and gets secreted to the extracellular matrix via non-classical mechanisms. TG2 has been associated with various human diseases including inflammation, cancer, fibrosis, cardiovascular disease, neurodegenerative diseases, celiac disease in which it plays either a protective role, or contributes to the pathogenesis. Thus modulating the biological activities of TG2 in these diseases will have a therapeutic value.
Key words: Transglutaminase / Inflammation / Cancer / Fibrosis / Cardiovascular Disease / Neurodegenerative Disease / Celiac Disease
© Author(s) 2017. This article is published with open access by China Medical University
Open Access This article is distributed under terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided original author(s) and source are credited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.